Literature DB >> 444501

Influence of the energetic state of mitochondria on the inhibition of oxidative phosphorylation by N-ethylmaleimide.

K Le Quoc, D Le Quoc, Y Gaudemer.   

Abstract

N-Ethylmaleimide inhibitory effect on oxidative phosphorylation, adenylic nucleotide translocation, succinate dehydrogenase and succinoxidase activities was studied as a function of the energetic state of mitochondria. 1. Using a reversible thiol reagent (mersalyl), in order to protect the phosphate carrier against irreversible action of N-ethylmaleimide, it was found that: (a) when mersalyl-pretreated mitochondria were in a 'non-energized' state, i.e. preincubated without a substrate and in the presence of rotenone, only a slight inhibition of succinate oxidation coupled to ATP synthesis by N-ethylmaleimide was observed. (b) when mersalyl-pretreated mitochondria were in an 'energized' state, i.e. preincubated in the presence of an oxidizable substrate, N-ethylmaleimide strongly inhibited the coupled oxidation of succinate. 2. Mitochondrial energization was also shown to enhavce the inhibitory effect of N-ethylmaleimide on adenylic nucleotide translocation and succinoxidase activity. However, other sulphydrul groups seem to be involved in the inhibition mechanism, but their function is unknown. 3. As N-ethylmaleimide inhibitory effect increased, an enhancement of N-[14C]ethylmaleimide binding to mitochondrial sulphydryl groups was obtained.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444501     DOI: 10.1016/0005-2728(79)90053-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Study of the effect of SH-groups on respiration and swelling of rat heart mitochondria.

Authors:  S M Korotkov; V P Nesterov; N N Ryabchikov
Journal:  Dokl Biochem Biophys       Date:  2008 Jul-Aug       Impact factor: 0.788

2.  N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-21       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.